ARCHIVES

ODAC Recommends Fludarabine Approval for Refractory CLL

This article is from The Cancer Letter archive.

Vol. 16 No. 36 | September 21, 1990

Download PDF Visit The Full Archive

Related Articles

Under A Flat Budget, NIH Suspends Grant Increases, May restore Funds Later.

November 24, 2000

Gallo, Rosenberg, Bishop, Varmus Win GM Awards

June 15, 1984

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

March 29, 2013

AACR Plans Office in Singapore.

November 30, 2007

NCI Bioinformatics After Kenneth Buetow: Varmus Launches Fundamental Redesign

January 6, 2012

Medicare plans to cut oncology payments on Jan. 1 unless Congress intervenes.

October 17, 2003